M&G Investment Management’s Medifast MED Stock Holding History

M&G Investment Management’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-3,510	Closed	-$576K	–	478
2020 Q3	$576K	Buy	+3,510	New	+$578K	0.01%	351

Other funds holding MED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

M&G Investment Management's MED Position: Q4 2020 in Review

M&G Investment Management sold out of Medifast (MED) in Q4 2020, closing a stake of 3,510 shares — an estimated $576K sold.

M&G Investment Management first reported a position in MED in Q3 2020 and held it in 1 quarter. The position peaked at $576K in Q3 2020. 261 funds tracked by Wall St. Rank hold MED as of Q4 2020.

M&G Investment Management reported no remaining Medifast position as of Q4 2020 after selling out during the quarter.
M&G Investment Management sold 3,510 Medifast shares in Q4 2020, an estimated $576K.
M&G Investment Management first reported a position in Medifast in Q3 2020 and held it in 1 quarter.
M&G Investment Management's Medifast position peaked at $576K in Q3 2020.
261 funds tracked by Wall St. Rank held Medifast as of Q4 2020.

Based on M&G Investment Management's 13F filing for Q4 2020, filed 2 Feb 2021.